Transmembrane Protein 87b
Introduction
Background
TMEM87B (Transmembrane Protein 87B) encodes a protein that is characterized by its presence within cellular membranes. Transmembrane proteins are integral components of cell structure and function, acting as gatekeepers and communicators across the cell's boundaries. They are involved in a vast array of biological processes, making genes like TMEM87B subjects of scientific interest for understanding fundamental cellular mechanisms.
Biological Basis
As a transmembrane protein, TMEM87B is embedded in the lipid bilayer of a cell membrane, meaning it has parts that span the membrane, as well as regions exposed to the inside and outside of the cell. This structural arrangement allows transmembrane proteins to perform critical functions such as transporting molecules, receiving signals from the extracellular environment, or forming channels that regulate ion flow. While the precise molecular functions and specific pathways involving TMEM87B are areas of ongoing research, its classification suggests a role in mediating interactions across cellular compartments.
Clinical Relevance
Disruptions in the function or expression of transmembrane proteins can have significant consequences for human health. Such proteins are often implicated in various diseases because of their fundamental roles in cellular processes like nutrient uptake, waste removal, and cell-to-cell signaling. Therefore, understanding the normal and abnormal functions of TMEM87B could provide insights into disease pathogenesis and potentially identify novel therapeutic targets.
Social Importance
The study of genes like TMEM87B holds considerable social importance by contributing to a deeper understanding of human biology and disease. Transmembrane proteins are frequently targeted by pharmaceutical drugs due to their accessibility on the cell surface and their involvement in numerous physiological processes. Elucidating the roles of TMEM87B could pave the way for new diagnostic tools, personalized medicine approaches, or the development of treatments for conditions where this protein's activity is altered, ultimately benefiting public health and improving quality of life.
Methodological and Statistical Considerations
Studies on transmembrane protein 87b often face limitations in statistical power, particularly for detecting genetic effects of modest size, given the extensive multiple testing inherent in genome-wide association studies (GWAS). [1] Many reported p-values may be unadjusted for these multiple comparisons, meaning that while some studies had power to detect associations explaining 4% or more of phenotypic variation, smaller effects could be missed or represent false positives. [2] This necessitates careful interpretation of statistical significance and highlights the challenge of distinguishing true associations from chance findings in a large number of tests. [3]
The interpretation of estimated effect sizes also requires careful consideration, as they may be influenced by study design, such as averaging observations over individuals or monozygotic twins, which can impact the proportion of phenotypic variance explained in the overall population. [2] Furthermore, early GWAS often utilized only a subset of available SNPs from resources like HapMap, potentially limiting comprehensive coverage of genetic variation and leading to missed associations or an incomplete understanding of candidate genes. [4] This partial coverage can hinder the identification of all relevant genetic loci and the precise localization of causal variants.
Generalizability and Phenotype Characterization
A significant limitation is the generalizability of findings, as many cohorts are predominantly composed of individuals of white European ancestry and specific age ranges, such as middle-aged to elderly populations. [5] While some studies employed methods to mitigate population stratification, the homogeneity of study populations restricts the applicability of results to younger individuals or those of diverse ethnic and racial backgrounds. [6] Additionally, the timing of DNA collection, such as during later examinations in longitudinal studies, could introduce survival bias, potentially skewing the observed genetic associations. [5]
Variability in phenotype measurement strategies across studies, including averaging traits over multiple examinations or observations, can influence the consistency and comparability of results. [1] Although rigorous quality control measures are often applied to biomarker phenotypes, the precise definition and measurement of complex traits can still pose challenges for replication and cross-study comparisons. [5] Such differences in phenotyping may contribute to the difficulty in replicating previously reported associations, even when statistical power is adequate.
Unaccounted Factors and Remaining Knowledge Gaps
The current understanding of genetic influences often lacks a comprehensive consideration of gene-environment interactions, which can modulate how genetic variants affect phenotypes. [1] For instance, the impact of certain genetic associations on traits may vary significantly depending on environmental factors like dietary intake, an area largely unexplored in many studies. [1] Failing to account for these complex interactions means that observed genetic effects might be context-specific and not universally applicable, representing a crucial gap in current research.
A fundamental challenge remains in validating initial GWAS findings through replication in independent cohorts, as many associations, even those with strong statistical support, may not consistently replicate across studies. [5] This could be due to differences in study design, population characteristics, or the potential for false positive findings in initial exploratory analyses. [5] Moreover, while some associations point to cis-acting regulatory variants or known protein products, the precise causal mechanisms for many identified loci, including the role of copy number variants or unknown causal variants in linkage disequilibrium, often remain to be fully elucidated, requiring further functional follow-up. [7] The presence of commercial sponsorship and employee involvement in some studies also suggests a potential, though unstated, influence on research priorities or interpretation. [8]
Variants
Genetic variations play a crucial role in modulating various biological processes, including coagulation, inflammation, lipid metabolism, and cellular signaling, which can collectively influence the function and environment of transmembrane proteins such as transmembrane protein 87b (TMEM87B). Several single nucleotide polymorphisms (SNPs) have been identified within or near genes that encode key components of these pathways, suggesting their broad implications in human health.
Variants associated with the kallikrein-kinin and coagulation systems, such as KLKB1 rs4241818, F12 rs2731673, and SERPINE2 rs68066031, are central to regulating blood clot formation and inflammatory responses. KLKB1 encodes plasma kallikrein, an enzyme vital for the kinin-kallikrein system, affecting blood pressure regulation and inflammation, while F12 encodes Coagulation Factor XII, which initiates the intrinsic coagulation pathway. [9] A variant like rs2731673 in or near F12 could alter the efficiency of this pathway, thereby impacting overall hemostasis and inflammatory processes. SERPINE2 (also known as PAI-2) is a serine protease inhibitor, regulating proteases involved in fibrinolysis and tissue remodeling. Disruptions in these systems can affect cell-extracellular matrix interactions and the cellular microenvironment, potentially influencing the activity or localization of transmembrane proteins like TMEM87B. [4] Additionally, the rs704 variant associated with VTN (Vitronectin) and SARM1 highlights roles in cell adhesion, spreading, migration, and innate immunity; vitronectin is a multi-functional glycoprotein involved in hemostasis and cell attachment, which could modify the cellular surface landscape where TMEM87B resides.
Other variants impact lipid metabolism, complement regulation, and protein processing, further connecting to the broader cellular context of TMEM87B. For instance, HRG (Histidine Rich Glycoprotein) and its antisense RNA HRG-AS1 are associated with variants like rs2228243 and rs9878767. HRG is known to bind various molecules, influencing angiogenesis, coagulation, and immune responses, making it a key player in tissue homeostasis and inflammation. [5] The CFH rs10801555 variant is significant for Complement Factor H, a critical regulator of the alternative complement pathway, preventing immune-mediated damage to host cells. Alterations in complement regulation can lead to chronic inflammation and tissue damage, potentially affecting the integrity and function of cell surface proteins. The PCSK6 rs7172696 variant is linked to Proprotein Convertase Subtilisin/Kexin Type 6, an enzyme that processes precursor proteins into their active forms, impacting diverse pathways including lipid metabolism and cell adhesion. [10] Furthermore, the rs12331618 variant, associated with CYP4V2 and KLKB1, points to a connection between fatty acid metabolism—where CYP4V2 is involved in the hydroxylation of long-chain fatty acids—and the kallikrein-kinin system, potentially influencing membrane lipid composition and signaling pathways that intersect with TMEM87B function.
The GRK6 rs2731673 variant is particularly relevant to cellular signaling, as GRK6 (G Protein-Coupled Receptor Kinase 6) is involved in the desensitization and regulation of G protein-coupled receptors (GPCRs). GPCRs are integral transmembrane proteins that mediate a vast array of physiological responses by transmitting extracellular signals across the cell membrane. The rs2731673 variant, also associated with F12, may influence how cells respond to external stimuli, thereby broadly impacting cellular processes such as migration, proliferation, and inflammation. [11] Such regulatory changes can have downstream effects on other transmembrane proteins, including TMEM87B, which may be involved in cell adhesion or immune modulation. The collective impact of these diverse variants on coagulation, inflammation, lipid metabolism, and cellular signaling pathways suggests a complex interplay that ultimately shapes the cellular environment and the activity of integral membrane proteins like TMEM87B.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs2228243 | HRG-AS1, HRG | KAZALD1/VCAM1 protein level ratio in blood blood protein amount dual specificity mitogen-activated protein kinase kinase 4 measurement transmembrane protein 87b measurement leucine-rich PPR motif-containing protein, mitochondrial measurement |
| rs4241818 | KLKB1 | blood protein amount drebrin-like protein measurement progonadoliberin-1 measurement transmembrane protein 87b measurement cadherin-15 measurement |
| rs704 | VTN, SARM1 | blood protein amount heel bone mineral density tumor necrosis factor receptor superfamily member 11B amount low density lipoprotein cholesterol measurement protein measurement |
| rs68066031 | SERPINE2 | blood protein amount platelet-derived growth factor complex BB dimer amount platelet volume glia-derived nexin measurement C-C motif chemokine 14 measurement |
| rs2731673 | GRK6, F12 | vascular endothelial growth factor D measurement dipeptidase 2 measurement tRNA (guanine-N(7)-)-methyltransferase measurement transmembrane protein 87b measurement neurexin-1 measurement |
| rs9878767 | HRG, HRG-AS1 | transmembrane protein 87b measurement |
| rs10801555 | CFH | age-related macular degeneration low-density lipoprotein receptor-related protein 1B measurement level of phosphomevalonate kinase in blood serum protein GPR107 measurement gigaxonin measurement |
| rs12331618 | CYP4V2 - KLKB1 | cardiac troponin I measurement blood protein amount level of leukocyte cell-derived chemotaxin-2 in blood serum tyrosine measurement transmembrane protein 87b measurement |
| rs7172696 | PCSK6 | glia-derived nexin measurement UDP-glucuronosyltransferase 2A1 measurement transmembrane protein 87b measurement protein measurement Fc receptor-like protein 4 measurement |
Membrane Transport and Metabolic Regulation
Transmembrane protein 87b, as an integral membrane protein, may play a critical role in cellular metabolism by mediating the transport of specific molecules across biological membranes. This function is essential for maintaining cellular homeostasis and regulating metabolic flux. For instance, other facilitative glucose transporters, such as SLC2A9 (GLUT9), are known to influence serum urate concentrations and excretion, as well as being involved in fructose metabolism, demonstrating how transmembrane proteins control the movement of key metabolites. [12] Similarly, other urate anion exchangers like SLC22A12 regulate blood urate levels, highlighting the importance of transmembrane proteins in maintaining solute balance. [13]
Beyond transport, transmembrane proteins can also function as enzymes directly involved in metabolic pathways. For example, the hepatic enzyme HMGCR, an ER transmembrane protein, is a central regulator of the mevalonate pathway, which is crucial for cholesterol biosynthesis. [14] This underscores how transmembrane proteins are not only conduits but also active participants in fundamental anabolic processes. Furthermore, proteins like ANGPTL3 and ANGPTL4 regulate lipid metabolism, with ANGPTL4 acting as a potent hyperlipidemia-inducing factor and an inhibitor of lipoprotein lipase, illustrating the diverse metabolic regulatory roles of membrane-associated proteins. [15]
Signal Transduction and Transcriptional Control
Transmembrane protein 87b, potentially functioning as a receptor or an accessory protein within the cell membrane, may play a role in initiating and propagating intracellular signaling cascades. Similar to the MC4R receptor, which is associated with waist circumference and insulin resistance, this protein could respond to extracellular stimuli to trigger downstream events. [16] Such signaling often involves the activation of protein kinase cascades, like those controlled by the Tribbles family of proteins, which regulate mitogen-activated protein kinase (MAPK) pathways essential for cellular responses. [17]
The activation of these membrane-proximal signaling pathways can ultimately lead to the regulation of gene expression through transcription factors. For instance, the transcription factor SREBP-2 plays a role in linking isoprenoid and adenosylcobalamin metabolism, suggesting a broader regulatory network that could involve signals transduced by transmembrane proteins. [18] Furthermore, receptor-related proteins, such as LRP, interact with transcriptional regulators like MafB, demonstrating how transmembrane proteins can directly influence gene regulation and cellular differentiation. [19]
Protein Trafficking and Post-Translational Dynamics
The proper function of transmembrane protein 87b, like other membrane proteins, is heavily reliant on precise biogenesis, trafficking, and post-translational modifications. Proteins such as Sam50 are crucial for the membrane insertion and assembly machinery of the mitochondrial outer membrane, highlighting the complex mechanisms required for integrating transmembrane components into their correct cellular locations. [20] Similarly, Erlin-1 and Erlin-2 function to define lipid-raft-like domains within the endoplasmic reticulum, which are specialized membrane regions that organize protein complexes and facilitate proper protein localization and function. [21]
Post-translational regulatory mechanisms, including alternative splicing, can significantly impact the structure and function of transmembrane proteins. For example, common single nucleotide polymorphisms in HMGCR affect the alternative splicing of exon 13, which in turn influences LDL-cholesterol levels. [22] Moreover, alternative splicing has been shown to alter the trafficking of other facilitative glucose transporter proteins, such as GLUT9 (SLC2A9), demonstrating a key regulatory layer that dictates the availability and activity of transmembrane proteins at the cell surface or within organelles. [23]
Interconnected Systems and Disease Implications
The functional roles of transmembrane protein 87b are likely integrated into complex biological networks, exhibiting crosstalk with various other pathways and contributing to systems-level regulation. For instance, the regulation of urate levels by transmembrane transporters like SLC2A9 is interconnected with fructose metabolism and has broad implications for conditions such as gout, metabolic syndrome, and renal disease. [24] This illustrates how the dysregulation of a single transmembrane protein's function can lead to cascading effects across multiple physiological systems.
Genetic variations influencing transmembrane proteins, such as those in HMGCR impacting LDL-cholesterol or in SLC2A9 affecting serum uric acid, underscore their critical role in disease pathophysiology. [22] These genetic associations reveal how subtle changes in transmembrane protein function can manifest as significant clinical phenotypes, including dyslipidemia and hyperuricemia. Understanding these interconnected mechanisms and pathway dysregulations is crucial for identifying potential therapeutic targets and developing strategies to manage diseases linked to transmembrane protein function. [25]
References
[1] Vasan, R.S. et al. "Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study." BMC Medical Genetics, vol. 8, 2007.
[2] Benyamin, B. et al. "Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels." The American Journal of Human Genetics, vol. 84, no. 1, 2009, pp. 60-65.
[3] Wallace, C. et al. "Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia." The American Journal of Human Genetics, vol. 82, no. 1, 2008, pp. 139-149.
[4] Yang, Q. et al. "Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study." BMC Medical Genetics, vol. 8, 2007.
[5] Benjamin, E.J. et al. "Genome-wide association with select biomarker traits in the Framingham Heart Study." BMC Medical Genetics, vol. 8, 2007.
[6] Pare, G. et al. "Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women." PLoS Genetics, vol. 4, no. 7, 2008, e1000118.
[7] Melzer, D. et al. "A genome-wide association study identifies protein quantitative trait loci (pQTLs)." PLoS Genetics, vol. 4, no. 5, 2008, e1000072.
[8] Yuan, X. et al. "Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes." The American Journal of Human Genetics, 2009.
[9] Reiner, Alex P., et al. "Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein." The American Journal of Human Genetics, vol. 82, no. 5, 2008, pp. 1193-201.
[10] Sabatti, C. et al. "Genome-wide association analysis of metabolic traits in a birth cohort from a founder population." Nature Genetics, vol. 40, no. 12, 2008, pp. 1394-1403.
[11] Wilk, J. B., et al. "Framingham Heart Study genome-wide association: results for pulmonary function measures." BMC Medical Genetics, vol. 8, no. Suppl 1, 2007, pp. S8.
[12] Vitart, V., et al. "SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout." Nat Genet, vol. 40, no. 4, 2008, pp. 437-442.
[13] Enomoto, A., et al. "Molecular identification of a renal urate anion exchanger that regulates blood urate levels." Nature, vol. 417, no. 6892, 2002, pp. 447-452.
[14] Edwards, P.A., Lemongello, D., & Fogelman, A.M. "Improved methods for the solubilization and assay of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase." J Lipid Res, vol. 20, no. 1, 1979, pp. 40-46.
[15] Koishi, R., et al. "Angptl3 regulates lipid metabolism in mice." Nat Genet, vol. 30, no. 2, 2002, pp. 151-157.
[16] Kooner, J.S., et al. "Common genetic variation near MC4R is associated with waist circumference and insulin resistance." Nat. Genet., vol. 40, no. 6, 2008, pp. 716–718.
[17] Kiss-Toth, E., et al. "Human tribbles, a protein family controlling mitogen-activated protein kinase cascades." J Biol Chem, vol. 279, no. 40, 2004, pp. 42703-42708.
[18] Murphy, C., et al. "Regulation by SREBP-2 defines a potential link between isoprenoid and adenosylcobalamin metabolism." Biochem Biophys Res Commun, vol. 355, no. 2, 2007, pp. 359-364.
[19] Petersen, H.H., et al. "Low-density lipoprotein receptor-related protein interacts with MafB, a regulator of hindbrain development." FEBS Lett., vol. 565, no. 1-3, 2004, pp. 23-27.
[20] Kozjak, V., et al. "An essential role of Sam50 in the protein sorting and assembly machinery of the mitochondrial outer membrane." J. Biol. Chem., vol. 278, no. 48, 2003, pp. 48520-48523.
[21] Browman, D.T., et al. "Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER." J. Cell Sci., vol. 119, no. 15, 2006, pp. 3149-3160.
[22] Burkhardt, R., et al. "Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13." Arterioscler Thromb Vasc Biol, vol. 28, no. 11, 2008, pp. 2009-2016.
[23] Augustin, R., et al. "Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking." J Biol Chem, vol. 279, no. 16, 2004, pp. 16229-16236.
[24] McArdle, P.F., et al. "Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish." Arthritis Rheum, vol. 56, no. 11, 2007, pp. 3820-3828.
[25] Kathiresan, S., et al. "Common variants at 30 loci contribute to polygenic dyslipidemia." Nat Genet, vol. 40, no. 2, 2008, pp. 189-197.